Clinical Trial Results: A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating multiple immunotherapy-based combinations in locally advanced unresectable or metastatic gastric/GEJ cancer and esophageal cancer; st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Carcinoma
• Gastric Adenocarcinoma
• Gastroesophageal Junction Adenocarcinoma

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2026-08-03